Overview
- Leading crypto ETP issuer 21Shares submitted a U.S. application on October 20 for a spot ETF designed to give investors direct exposure to Injective’s INJ token.
- The proposed fund would custody physical INJ in secure cold storage to track the asset’s spot price.
- Injective’s official X account shared the filing, increasing awareness of the application among market participants.
- INJ traded near $8.75 and maintained support above $8.00 after briefly dipping to about $7.80 earlier in October.
- The filing follows a July INJ ETF application by Canary Capital, with SEC review pending and no approval timeline announced.